Financial Performance - For the three months ended September 30, 2023, the company reported a net income of $679,159, with operating costs of $533,016 and interest earned on marketable securities of $1,232,175[131]. - For the nine months ended September 30, 2023, the company had a net income of $2,399,326, consisting of operating costs of $1,682,782 and interest earned of $4,082,108[131]. - The company incurred cash used in operating activities of $440,994 for the nine months ended September 30, 2023[136]. - As of September 30, 2023, the company has not generated any operating revenues and only incurs non-operating income from interest on marketable securities held in the Trust Account[145]. Cash and Securities - As of September 30, 2023, the company held marketable securities in the Trust Account amounting to $81,950,013, primarily in a money market fund and government bonds[138]. - The company had cash available of $80,473 and a working capital deficit of $4,171,122 as of September 30, 2023[139]. - A total of $640,000 has been deposited into the Trust Account as required contributions as of November 17, 2023[128]. - The Class A ordinary shares subject to possible redemption amount to $81,950,0138, classified as temporary equity as of September 30, 2023[150]. Business Combination and Obligations - The company has until February 23, 2024, to consummate its initial business combination following the approval of the Second Extension Proposal[127]. - The company expects to continue incurring significant costs in pursuit of a business combination, raising doubts about its ability to sustain operations for at least the next 12 months[144]. - The holders of 10,415,452 Class A ordinary shares redeemed their shares for approximately $109.31 million at a redemption price of $10.49 per share[126]. - In connection with the initial Business Combination, the company is obligated to pay a deferred underwriting commission of $5,999,964, which is 3.0% of the total gross proceeds raised in the offering[148]. - The company has a monthly obligation of $10,000 to its Sponsor for office space and administrative support, which began on November 23, 2021[147]. Financial Instruments and Reporting - The company has classified its warrants as equity instruments based on specific terms and applicable guidance[151]. - As of September 30, 2023, the company did not have any dilutive securities, resulting in diluted income (loss) per share being the same as basic income (loss) per share[152]. - Management does not anticipate that any recently issued accounting standards will materially affect the financial statements[153]. - The company is classified as a smaller reporting company and is not required to provide additional market risk disclosures[154].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41079 INFINT ACQUISITION CORPORATION (Exact name of registrant as specified in its charter) | Cayman Islands | 98-1602649 | | -- ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41079 INFINT ACQUISITION CORPORATION (Exact name of registrant as specified in its charter) | Cayman Islands | 98-1602649 | | - ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41079 INFINT ACQUISITION CORPORATION (Exact name of registrant as specified in its charter) Cayman Islands 98-1602649 (State or other jurisdiction ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41079 INFINT ACQUISITION CORPORATION (Exact name of registrant as specified in its charter) | Cayman Islands | 98-1602649 | ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41079 INFINT ACQUISITION CORPORATION (Exact name of registrant as specified in its charter) | Cayman Islands | 98-1602649 | | -- ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41079 INFINT ACQUISITION CORPORATION (Exact name of registrant as specified in its charter) | Cayman Islands | 98-1602649 | | - ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Cayman Islands 98-1602649 (I.R.S. Employer Identification Number) 32 Broadway, Suite 401 New York, NY 10004 (Address of principal executive offices) (Zip Code) 212-287-5010 ☐ TRANSI ...